What is the role for idelalisib and duvelisib in CLL?
How to generate an anticancer immune response in multiple myeloma
Selinexor for CLL - mechanism of action and combination with ibrutinib
Venetoclax for multiple myeloma - mechanism of action and next steps
Daratumumab in multiple myeloma: an overview of 3 key trials
Niels van de Donk